Anxiety Disorder Treatment Guidelines

Pharmacotherapy Options

The American College of Neuropsychopharmacology recommends Selective Serotonin Reuptake Inhibitors (SSRIs) or Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) as first-line pharmacological treatments for anxiety disorders, due to their effectiveness and favorable side effect profiles 1
SSRIs, such as sertraline and escitalopram, are suggested as first-line pharmacological treatments due to their effectiveness and favorable side effect profiles 2
SNRIs, such as venlafaxine, are also recommended as first-line options with similar efficacy to SSRIs 1
For elderly patients, sertraline and escitalopram are preferred due to their lower potential for drug interactions 3
Paroxetine and fluoxetine should generally be avoided in older adults due to higher rates of adverse effects 3

Cognitive Behavioral Therapy (CBT) is the psychotherapy with the highest level of evidence for anxiety disorders, according to the American College of Neuropsychopharmacology 1
Individual CBT sessions are generally preferred over group therapy due to superior clinical effectiveness 1
Self-help CBT with professional support is a viable alternative if face-to-face CBT is not feasible or desired by the patient 1, 3
CBT should be administered by a skilled therapist following specific protocols, such as the Clark and Wells model or the Heimberg model for social anxiety disorder 1

For a first episode of anxiety, pharmacological treatment should continue for at least 4-12 months after symptom remission 3
For recurrent anxiety, longer-term or indefinite treatment may be beneficial 3, 2
Regular monitoring using validated outcome measures is recommended 4

While both pharmacotherapy and psychotherapy are effective individually, there is insufficient evidence to make a recommendation regarding combined treatment, according to the American College of Neuropsychopharmacology 1, 5